These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 14632590)

  • 41. [Patients reported adverse drug reactions: what's happening in Europe].
    Herxheimer A; Crombag R; Alves TL
    Assist Inferm Ric; 2011; 30(1):42-7. PubMed ID: 21539077
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of the reproducibility of the Naranjo Adverse Drug Reaction Probability Scale score in published case reports.
    Liang R; Borgundvaag B; McIntyre M; Thwaites C; Ragan K; Wyllie A
    Pharmacotherapy; 2014 Nov; 34(11):1159-66. PubMed ID: 25266970
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Toward standardized reporting of drug interactions: the READI checklist for anecdotal reports.
    Aronson JK
    Expert Rev Clin Pharmacol; 2015; 8(4):399-409. PubMed ID: 26018632
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluating the risk of patient re-identification from adverse drug event reports.
    El Emam K; Dankar FK; Neisa A; Jonker E
    BMC Med Inform Decis Mak; 2013 Oct; 13():114. PubMed ID: 24094134
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detecting Adverse Drug Events: Accuracy and Generalizability.
    Walter SR; Gallego B
    Ther Innov Regul Sci; 2019 Nov; 53(6):795-796. PubMed ID: 30595045
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Case reports of suspected adverse drug reactions: case reports generate signals efficiently.
    Russmann S
    BMJ; 2006 Feb; 332(7539):488. PubMed ID: 16497771
    [No Abstract]   [Full Text] [Related]  

  • 47. Poor reporting of adverse effects in clinical trials: in urology too.
    Prescrire Int; 2011; 20(118):184. PubMed ID: 21751754
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Concordance and predictive value of two adverse drug event data sets.
    Cami A; Reis BY
    BMC Med Inform Decis Mak; 2014 Aug; 14():74. PubMed ID: 25149292
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dose discrepancies between the Physicians' Desk Reference and the medical literature, and their possible role in the high incidence of dose-related adverse drug events.
    Cohen JS
    Arch Intern Med; 2001 Apr; 161(7):957-64. PubMed ID: 11295958
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Improving Pediatric Adverse Drug Event Reporting through Clinical Pharmacy Services.
    Crowther DM; Buck ML; McCarthy MW; Barton VW
    J Pediatr Pharmacol Ther; 2011 Oct; 16(4):285-90. PubMed ID: 22768013
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Published cases of adverse drug reactions: has the quality of reporting improved over time?
    Kane-Gill SL; Smithburger PL; Williams EA; Felton MA; Wang N; Seybert AL
    Ther Adv Drug Saf; 2015 Apr; 6(2):38-44. PubMed ID: 25922652
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Potential risks and prevention, Part 2: Drug-induced permanent disabilities.
    Kelly WN
    Am J Health Syst Pharm; 2001 Jul; 58(14):1325-9. PubMed ID: 11471480
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An evaluation of interventions designed to stimulate physician reporting of adverse drug events.
    Juergens JP; Szeinbach SL; Janssen MJ; Brown TR; Garner DD
    Top Hosp Pharm Manage; 1992 Jul; 12(2):12-8. PubMed ID: 10128725
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Causality assessment of adverse drug reactions: comparison of the results obtained from published decisional algorithms and from the evaluations of an expert panel, according to different levels of imputability.
    Macedo AF; Marques FB; Ribeiro CF; Teixeira F
    J Clin Pharm Ther; 2003 Apr; 28(2):137-43. PubMed ID: 12713611
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of 500 spontaneous and 500 published reports of adverse drug reactions.
    Haramburu F; Bégaud B; Péré JC
    Eur J Clin Pharmacol; 1990; 39(3):287-8. PubMed ID: 2257868
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adverse Drug Event Reporting From Clinical Care: Mixed-Methods Analysis for a Minimum Required Dataset.
    Peddie D; Small SS; Badke K; Bailey C; Balka E; Hohl CM
    JMIR Med Inform; 2018 Jun; 6(2):e10248. PubMed ID: 29954724
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Peer review and the process of publishing of adverse drug event reports.
    Karch SB
    J Forensic Leg Med; 2007 Feb; 14(2):79-84. PubMed ID: 17654770
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Estimating the frequency of adverse drug effects from spontaneous ADE reports.
    Int J Risk Saf Med; 1994; 5(2):145-66. PubMed ID: 23511391
    [No Abstract]   [Full Text] [Related]  

  • 59. Importance of Publishing Adverse Drug Reaction Case Reports: Promoting Public Health and Advancing Pharmacology and Therapeutics.
    Shah RR
    Drug Saf Case Rep; 2017 Sep; 4(1):11. PubMed ID: 28933008
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adverse Drug Event Ontology: Gap Analysis for Clinical Surveillance Application.
    Adam TJ; Wang J
    AMIA Jt Summits Transl Sci Proc; 2015; 2015():16-20. PubMed ID: 26306223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.